CapsoVision, Inc. CV
6.44 USD +0.12 (+1.90%)
At closeNov 9, 2026, 4:01 PM EST
6.44 0.00 0.00%
After hours · Nov 9, 4:01 PM ET
6.31 Day range 6.56
4.50 52-week range 15.37
- YTD
- -39.76%
- 1 year
- +36.15%
News
benzinga.com CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System AI Highlights is designed to support physicians in the review of small bowel capsule endoscopy studies collected from adult and pediatric patients (over two years of age) in whom the study was…
benzinga.com CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M CapsoVision, Inc.3,163,444 Shares of Common Stock We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors…
benzinga.com CapsoVision Q2 2026 Earnings Call Transcript CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call…
benzinga.com CapsoVision Files Prospectus For Up To $250M Offering Of Common Stock, Preferred Stock, Warrants, Rights And Units CapsoVision, Inc.$250,000,000Common StockPreferred StockWarrantsRightsUnits From time to time, we may offer to sell the securities described in this prospectus separately or together in any…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.
benzinga.com Transcript: CapsoVision Q1 2026 Earnings Conference Call - benzinga.com CapsoVision Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $2.792M Miss $3.188M Estimate CapsoVision (NASDAQ:CV) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 25 percent. This is a 93.98 percent increase over losses of $(2.49)…
benzinga.com Earnings Scheduled For May 14, 2026 - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10 Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.
benzinga.com CapsoVision Q4 EPS $0.02 Beats $(0.14) Estimate, Sales $3.918M Miss $4.151M Estimate. CapsoVision (NASDAQ:CV) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.14) by 113.79 percent. This is a 100.91 percent increase over losses of $(2.20)…- benzinga.com Earnings Scheduled For March 26, 2026
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com CapsoVision Closes $14M Private Placement In Public Equity Financing CapsoVision, Inc. (the "Company") (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the closing of a…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Benchmark Maintains Speculative Buy on CapsoVision, Raises Price Target to $14 Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and raises the price target from $5 to $14.
benzinga.com Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
benzinga.com CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday 
benzinga.com Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.
benzinga.com Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket 
benzinga.com Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket 
benzinga.com Broadcom, LightPath Technologies, Netskope And Other Big Stocks Moving Lower In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? CapsoVision shares surged in after-hours trading following the appointment of David Garcia as senior vice president of finance.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com CapsoVision Q3 EPS $(0.17) Misses $(0.11) Estimate, Sales $3.538M Miss $3.683M Estimate CapsoVision (NASDAQ:CV) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.11) by 54.55 percent. This is a 93.91 percent increase over losses of $(2.79)…
- benzinga.com Earnings Scheduled For November 13, 2025
benzinga.com CapsoVision Submits Breakthrough Device Designation Application To U.S. FDA For Its CapsoCam UGI Capsule Endoscopy System CapsoVision, Inc. (NASDAQ:CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that it has submitted an…- benzinga.com CapsoVision Kevin Lundquist Steps Down As CFO https://www.sec.gov/ix?doc=/Archives/edgar/data/0001378325/000137832525000018/cv-20250827.htm
- benzinga.com BPAX Reaches Key LibiGel® Safety Study Enrollment Target
- benzinga.com Central Vermont Reports Second Quarter Earnings RUTLAND, VT--(Marketwire - August 7, 2009) - Central Vermont Public Service (NYSE: CV) -- Year-to-date earnings of $12.4 million, or $1.04 per diluted share, up 10 cents from last year - $2.3 million…